Clinical Trials for Refractory Acute Leukemia of Ambiguous Lineage

Find clinical trials for refractory acute leukemia of ambiguous lineage. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia

NCT ID: NCT05761171

This clinical trial is exploring a new treatment for young children with certain types of leukemia that have either come back after previous treatment (relapsed) or did not respond to treatment (re...

Recruiting

Phase: PHASE2 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Buffalo, New York, United States +83 more

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

NCT ID: NCT04375631

This clinical trial is investigating a new treatment approach for patients with certain types of blood cancers, specifically those with relapsed or hard-to-treat forms of acute myeloid leukemia (AM...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions